Clinical Trials Logo

Post Operative Anterior Chamber Inflammation (Flare) clinical trials

View clinical trials related to Post Operative Anterior Chamber Inflammation (Flare).

Filter by:
  • None
  • Page 1

NCT ID: NCT01023724 Completed - Clinical trials for Post Operative Anterior Chamber Inflammation (Flare)

A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)

Start date: December 2009
Phase: Phase 4
Study type: Interventional

Approximately 50 patients undergoing cataract surgery will be randomized in an even allocation (1:1) into two treatment groups, either ketorolac 0.45% BID or bromfenac 0.09% BID. Patients will be instructed to begin dosing study medication in the operative eye the day before surgery and continue dosing until day 14. KOWA flare measurements will be performed at postoperative day one and postoperative day 14. The amount of anterior chamber inflammation (flare) will be objectively measured.